- Unique biological technology for nematode control
- Revolutionary production process
- First seed treatment for soybean cyst nematode: US launch in 2014
- Supports integrated offer across key crops
Monsanto shares should rise if the $129-per-share deal, including a massive break fee, is confirmed, while Bayer investors appear unsure whether to celebrate or mourn.
Bayer increases its latest offer to buy Monsanto, as regulators look closely at agribusiness mergers.
Bayer increases its latest offering to entice Monsanto, as regulators look closely at agribusiness mergers.